These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35670256)

  • 1. Pharmacogenomics: a tool to improve medication safety and efficacy in patients with cystic fibrosis.
    Sakon CM; Tillman EM
    Pharmacogenomics; 2022 Jun; 23(9):559-556. PubMed ID: 35670256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis.
    Anderson JD; Davis BH; Giang G; Jones A; Lee CR; Parker K; Searcy H; Benner K; Limdi NA; Guimbellot JS
    Clin Transl Sci; 2023 Apr; 16(4):662-672. PubMed ID: 36760155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunity for pharmacogenomic testing in patients with cystic fibrosis.
    Sakon C; Alicea LA; Patacca H; Brown CD; Skaar TC; Tillman EM
    Pediatr Pulmonol; 2022 Apr; 57(4):903-907. PubMed ID: 34967155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
    Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the pharmacogenomics of cystic fibrosis--an update.
    Sangiuolo F; D'Apice MR; Gambardella S; Di Daniele N; Novelli G
    Pharmacogenomics; 2004 Oct; 5(7):861-78. PubMed ID: 15469408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.
    Clancy JP; Johnson SG; Yee SW; McDonagh EM; Caudle KE; Klein TE; Cannavo M; Giacomini KM;
    Clin Pharmacol Ther; 2014 Jun; 95(6):592-7. PubMed ID: 24598717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics of cystic fibrosis.
    Pollard HB; Eidelman O; Jacobson KA; Srivastava M
    Mol Interv; 2001 Apr; 1(1):54-63. PubMed ID: 14993338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Pharmacogenomics: Applications in Nephrology.
    Adams SM; Crisamore KR; Empey PE
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1561-1571. PubMed ID: 29793969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis.
    Ren CL; Morgan RL; Oermann C; Resnick HE; Brady C; Campbell A; DeNagel R; Guill M; Hoag J; Lipton A; Newton T; Peters S; Willey-Courand DB; Naureckas ET
    Ann Am Thorac Soc; 2018 Mar; 15(3):271-280. PubMed ID: 29342367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the pharmacogenomics of cystic fibrosis.
    Sangiuolo F; D'Apice MR; Bruscia E; Lucidi V; Novelli G
    Pharmacogenomics; 2002 Jan; 3(1):75-87. PubMed ID: 11966405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprine.
    Daniel LL; Dickson AL; Chung CP
    Clin Rheumatol; 2021 Jan; 40(1):65-73. PubMed ID: 32617765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.
    Roosan D; Hwang A; Roosan MR
    Pharmacogenomics J; 2021 Feb; 21(1):1-7. PubMed ID: 32843688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps.
    Hoshitsuki K; Fernandez CA; Yang JJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S188-S192. PubMed ID: 34185912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Web-Based Pharmacogenomics Search Tool for Precision Medicine in Perioperative Care.
    Zarei S; Costas Y; Orozco G; Zaydlin M; Mirtar A; Abouali M; Diaz-Marty C; Akhlaghipour G; Fernandez Altamirano P; Gonzalez Cardona AR; Reiley LE; Mirzakhani H
    J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32708157
    [No Abstract]   [Full Text] [Related]  

  • 18. Medication selection by genotype: How genetics is changing drug prescribing and efficacy.
    Prows CA; Prows DR
    Am J Nurs; 2004 May; 104(5):60-70; quiz 71. PubMed ID: 15166720
    [No Abstract]   [Full Text] [Related]  

  • 19. Gentamicin in pharmacogenetic approach to treatment of cystic fibrosis.
    Hamilton JW
    Lancet; 2001 Dec; 358(9298):2014-6. PubMed ID: 11755605
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomics guidelines: Current status and future development.
    Guo C; Xie X; Li J; Huang L; Chen S; Li X; Yi X; Wu Q; Yang G; Zhou H; Liu JP; Chen X
    Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):689-693. PubMed ID: 31009088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.